IHL-42X

· Incannex Healthcare Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IHL-42X, covering 2025-01-17 to 2025-04-20. Get the full timeline:

Most recent: Clinical Trial Update: RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA [Phase 2, Phase 3]